Ebglyss 250 mg solution for injection in pre-filled syringe, Placebo, Ebglyss 250 mg solution for injection in pre-filled pen
M-17923-34
Phase 3 small_molecule active
Quick answer
Ebglyss 250 mg solution for injection in pre-filled syringe, Placebo, Ebglyss 250 mg solution for injection in pre-filled pen for Atopic Dermatitis is a Phase 3 program (small_molecule) at Almirall with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Almirall
- Indication
- Atopic Dermatitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active